Keyphrases
Hematopoietic Stem Cells
96%
Granulocyte Colony-stimulating Factor (G-CSF)
90%
Acute Myeloid Leukemia
89%
Multiple Myeloma
70%
T Cells
59%
C-X-C Chemokine Receptor Type 4 (CXCR4)
58%
Hematopoietic Stem Cell Mobilization
54%
Plerixafor
51%
VLA-4
49%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
41%
CXCR4 Antagonist
40%
AMD3100
39%
Graft-versus-host Disease (GvHD)
36%
Chimeric Antigen Receptor T Cells (CAR-T)
33%
CXCR4 Inhibitor
32%
Stem Cells
31%
CD34
28%
Myeloma Cells
28%
Bone Marrow
27%
Suicide Gene
26%
Relapsed or Refractory Acute Myeloid Leukemia
25%
P(LLA-CL)
23%
Peripheral Blood
22%
Flotetuzumab
22%
Allogeneic
22%
Erythrocytes
22%
Stem Cell Mobilization
22%
Motixafortide
21%
Acute Myeloid Leukemia Cells
20%
Bone Marrow Microenvironment
20%
Tumor
19%
Chemotherapy
19%
Hematological Malignancies
19%
CD123
19%
Chemosensitization
18%
Fratricide
18%
Myeloma
17%
Microenvironment
17%
Autologous Transplantation
16%
Leukemia
16%
Red Blood Cells
16%
Cancer Cells
15%
Leukemia Cells
15%
Cell Trafficking
15%
CD33
15%
Engraftment
15%
Cell Yield
14%
Azacitidine
14%
PET Imaging
14%
Bortezomib
14%
Immunology and Microbiology
Myeloid
100%
T Cell
74%
Plerixafor
67%
Granulocyte Colony-Stimulating Factor
64%
Multiple Myeloma
63%
Stem Cell
59%
Hematopoietic Stem Cell
58%
CXCR4
57%
CD34
50%
Mouse
48%
Immunotherapy
32%
Leukemia Cell
32%
Graft-Versus-Host Disease
28%
Flotetuzumab
25%
Hematopoietic Cell
23%
Engraftment
22%
CD3 Antigen
18%
Chimeric Antigen Receptor T-Cell
18%
Chimeric Antigen Receptor T-Cell Therapy
16%
Stem Cell Transplant
15%
Hemocyte
15%
Interleukin 7
15%
Positron Emission Tomography
15%
CD33
15%
Autotransplantation
14%
Chemosensitization
14%
Erythrocyte
14%
Myeloma Cell
14%
Cytokine Release Syndrome
12%
Bone Marrow Microenvironment
11%
Stromal Cell-Derived Factor 1
11%
Band 3
11%
Cell Transplantation
11%
Allogeneic Hematopoietic Stem Cell Transplantation
11%
Hematopoietic Stem Cell Transplantation
10%
Tumor Volume
10%
Allogeneic Stem Cell Transplantation
10%
Plasma Cell
9%
Tumor Cell
9%
B Cell
9%
Mouse Model
9%
Granulocyte
9%
Antibody Drug Conjugate
9%
CD8
8%
Stem Cell Transplantation
8%
Preclinical Study
8%
Peripheral Blood Stem Cell
8%
Herpes Simplex Virus
8%
Immune Landscape
8%
CD2
8%
Medicine and Dentistry
Multiple Myeloma
56%
Plerixafor
53%
Acute Myeloid Leukemia
47%
Granulocyte Colony Stimulating Factor
46%
Hematopoietic Stem Cell
38%
Neoplasm
33%
Stem Cell Mobilization
25%
Chemokine Receptor CXCR4 Antagonist
24%
Positron Emission Tomography
23%
Myeloma Cell
22%
Myeloma
21%
Copper 64
21%
Stem Cell
20%
T Cell
19%
Leukemia Cell
18%
Chemosensitization
16%
Immunotherapy
16%
Chimeric Antigen Receptor T-Cell
16%
Drug Resistance
15%
Flotetuzumab
14%
Bortezomib
14%
Stem Cell Transplant
14%
Chimeric Antigen Receptor
14%
Interleukin 7
14%
Azacitidine
14%
Zirconium 89
14%
Erythrocyte
14%
Radioactive Tracer
13%
Hematologic Malignancy
12%
In Vitro
12%
Positron Emission Tomography
11%
Myelodysplastic Syndrome
11%
Stromal Cell Derived Factor 1
11%
Hematopoietic Stem Cell Transplantation
11%
Bone Marrow Microenvironment
10%
Cytarabine
10%
CD8 Antigen
9%
Allogeneic Hematopoietic Stem Cell Transplantation
9%
Ex Vivo
9%
Overall Survival
9%
Malignant Neoplasm
9%
Imaging Agent
9%
Metastatic Carcinoma
9%
Allogeneic Stem Cell Transplantation
9%
Programmed Cell Death
9%
Granulocyte
9%
Hematopoietic Stem Cell
8%
Fluorodeoxyglucose F 18
8%
Dosimetry
8%
Cell Adhesion
8%